Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Main Index

View All
Multiple endocrine neoplasia type 2 (MEN2)
Mu-opioid receptor (MOR)
Muscarinic antagonist, in heart-transplanted patients
Muscle motor evoked potentials (mMEPs), in awake craniotomy
Muscle pain, succinylcholine and
Muscle paralysis
Muscle relaxants
Muscular dystrophy, and malignant hyperthermia
Musculocutaneous nerve, missed, in axillary block
Mustard procedure, for transposition of the great arteries
Myalgia
Myalgia, succinylcholine and
Myasthenia gravis (MG)
Myasthenic syndrome
Mycophenolate mofetil A.9. How are immunosuppressive drugs managed in kidney transplant recipients? B.3. How are routine medications and immunosuppressive medications managed in the perioperative period? D.2. What are immunosuppressive agents, and how do they affect anesthetic care?
Mycophenolate sodium A.9. How are immunosuppressive drugs managed in kidney transplant recipients? D.2. What are immunosuppressive agents, and how do they affect anesthetic care?
Myelogram, in low back pain
Myocardial contractility A.1. What is the differential diagnosis of low CO following cardiac surgery? B.4. What are the three major determinants of myocardial oxygen consumption? How are they measured clinically? in children, inhalation anesthetics and - C.5. What is the effect of inhalation anesthetics on airway reflexes, myocardial contractility, systemic vascular resistance (SVR), and pulmonary vascular resistance (PVR) in children?
Myocardial dysfunction, in sepsis
Myocardial Infarction and Cardiac Arrest (MICA) A.1. What are the preoperative predictors for perioperative major adverse cardiac events (MACE)? B.1. How should this patient be evaluated?
Myocardial infarction
Myocardial ischemia and postoperative myocardial infarction arterial switch procedure and CAD for noncardiac surgery - A.5. What is the incidence of perioperative myocardial injury, infarction, and MACE in patients with coronary artery disease (CAD) undergoing noncardiac surgery? hemodynamic consequences of - C.I-8. What are the hemodynamic consequences of myocardial ischemia? How can you detect myocardial ischemia? Is PAOP a sensitive indicator of myocardial ischemia? hypertension and infarction for noncardiac surgery - A.5. What is the incidence of perioperative myocardial injury, infarction, and MACE in patients with coronary artery disease (CAD) undergoing noncardiac surgery? mechanism of medical therapy to reduce incidence of - A.6. Which perioperative medical therapies would you employ to reduce the incidence of myocardial ischemia? monitoring, in abdominal aortic aneurysm surgery myocardial injury for noncardiac surgery - A.5. What is the incidence of perioperative myocardial injury, infarction, and MACE in patients with coronary artery disease (CAD) undergoing noncardiac surgery? perioperative - A.1. What are the preoperative predictors for perioperative major adverse cardiac events (MACE)? postoperative, hypothermia and - D.4. Is postoperative hypothermia associated with postoperative myocardial ischemia?
Myocardial oxygen consumption B.4. What are the three major determinants of myocardial oxygen consumption? How are they measured clinically? C.II-22. How would you preserve the myocardium during CPB? intra-aortic balloon pump and
Myocardial oxygen demand
Myocardial oxygen supply A.2. What are the determinants of myocardial oxygen demand? How are they measured clinically? A.3. What factors determine myocardial oxygen supply? B.3. Which factors determine myocardial oxygen supply?
Myocardial preservation, during cardiopulmonary bypass
Myocardial wall tension
Myometrial contractility
Myometrial hypotonia C.4. How is postpartum hemorrhage (PPH) defined, and what are the etiologies of this bleeding? C.5. After delivery of the fetus, the placenta is removed with some difficulty in one small area, and generalized oozing from the placental implantation site is noted. What is the most likely cause of this patient's bleeding?